Carbazochrome Sodium Sulfonate Injection 100mg/20mL (Carbazochrome Na Sulfonate IV “NISSIN”® / カルバゾクロムスルホン酸Na静注100mg「日新」)

JPY ¥5,000

Japanese Vascular Agent (Carbazochrome Sodium Sulfonate Hydrate 100mg/20mL). For intravenous injection or drip infusion to control hemorrhage due to decreased capillary resistance. 20mL x 50 vials (twist-luer polyethylene bottle). Mfd. by Nissin Pharmaceutical Co., Ltd., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥4,600
10 - 19 12% JPY ¥4,400
20 + 18% JPY ¥4,100
SKU: CAR-100-INJ Category:

Description

Product Overview / 商品概要

Carbazochrome Sodium Sulfonate Injection 100mg/20mL (カルバゾクロムスルホン酸Na静注100mg「日新」)
Generic: Carbazochrome Sodium Sulfonate Hydrate / カルバゾクロムスルホン酸ナトリウム水和物
Therapeutic Category: Vascular Agent / 対血管薬剤
Manufactured by: Nissin Pharmaceutical Co., Ltd. / 日新製薬株式会社

Composition & Specification / 組成・規格

Active Ingredient: Carbazochrome Sodium Sulfonate Hydrate (JP) 100mg per 20mL vial / 日本薬局方カルバゾクロムスルホン酸ナトリウム水和物100mg(1管20mL中)
Additives: Sodium bisulfite 1.4mg, D-Sorbitol 600mg, Propylene glycol 600mg, pH adjuster (per 20mL vial) / 亜硫酸水素ナトリウム1.4mg、D-ソルビトール600mg、プロピレングリコール600mg、pH調節剤(1管20mL中)
Appearance: Orange-yellow clear solution (aqueous injection); pH 5.5–6.2; Osmotic pressure ratio approx. 2 (relative to physiological saline)
外観: だいだい黄色澄明の液(水性注射剤)、pH 5.5~6.2、浸透圧比 約2(生理食塩液に対する比)

Indications / 効能効果

EN: Hemorrhagic tendency considered to be caused by decreased capillary resistance and increased permeability (e.g., purpura); Bleeding from skin, mucous membranes, or internal membranes, retinal hemorrhage, renal hemorrhage, and uterine hemorrhage due to decreased capillary resistance; Abnormal bleeding during or after surgery due to decreased capillary resistance
JA: ○毛細血管抵抗性の減弱及び透過性の亢進によると考えられる出血傾向(例えば紫斑病等)
○毛細血管抵抗性の減弱による皮膚あるいは粘膜及び内膜からの出血、眼底出血、腎出血、子宮出血
○毛細血管抵抗性の減弱による手術中・術後の異常出血

Dosage and Administration / 用法用量

EN: The usual adult dose is 25 to 100mg of Carbazochrome Sodium Sulfonate Hydrate per day, administered by intravenous injection or intravenous drip infusion. The dose may be adjusted according to age and symptoms.
JA: カルバゾクロムスルホン酸ナトリウム水和物として、通常成人1日25~100mgを静脈内注射又は点滴注射する。なお、年齢、症状により適宜増減する。

Contraindications / 禁忌

EN: Patients with a history of hypersensitivity to any component of this product; Patients with hereditary fructose intolerance
JA: ○本剤の成分に対し過敏症の既往歴のある患者
○遺伝性果糖不耐症の患者

Regulatory Information / 規制情報

Approval No.: 23000AMX00848000
Sales Started: July 1992 / 1992年7月
Classification Code: 873321
Storage: Store at room temperature / 室温保存
Shelf Life: 3 years / 3年

Packaging / 包装

Main Package (for sale): 20mL x 50 vials (twist-luer polyethylene bottle) / 20mL×50管(ツイストルアーポリエチレンボトル)
Other Available Packages (by special order): 20mL x 50 vials (twist-luer polyethylene bottle)

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Carbazochrome Sodium Sulfonate Injection 100mg/20mL (Carbazochrome Na Sulfonate IV “NISSIN”® / カルバゾクロムスルホン酸Na静注100mg「日新」)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Carbazochrome Sodium Sulfonate Injection 100mg

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.